These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Detection, evaluation, and treatment of pituitary microadenomas in patients with galactorrhea and amenorrhea. Chang RJ, Keye WR, Young JR, Wilson CB, Jaffe RB. Am J Obstet Gynecol; 1977 Jun 15; 128(4):356-63. PubMed ID: 559413 [Abstract] [Full Text] [Related]
7. Galactorrhea and hyperprolactinemia. Sakiyama R, Quan M. Obstet Gynecol Surv; 1983 Dec 15; 38(12):689-700. PubMed ID: 6361641 [Abstract] [Full Text] [Related]
8. Case-control study of galactorrhea and its relationship to the use of oral contraceptives. Taler SJ, Coulam CB, Annegers JF, Brittain EH. Obstet Gynecol; 1985 May 15; 65(5):665-8. PubMed ID: 4039047 [Abstract] [Full Text] [Related]
9. The amenorrhea, galactorrhea and hyperprolactinemia syndromes. Molitch ME, Reichlin S. Adv Intern Med; 1980 May 15; 26():37-65. PubMed ID: 6111899 [No Abstract] [Full Text] [Related]
17. Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity. Scarabin PY, Plu-Bureau G, Zitoun D, Bara L, Guize L, Samama MM. Thromb Haemost; 1995 Sep 15; 74(3):928-32. PubMed ID: 8571323 [Abstract] [Full Text] [Related]
18. [The importance of the prolactin level in the development and treatment of amenorrhea-galactorrhea caused by hormonal contraceptives]. Godó G, Sas M. Orv Hetil; 1980 May 04; 121(18):1059-62. PubMed ID: 7191080 [No Abstract] [Full Text] [Related]